Marlin's 3.7% portfolio return lagged the 10.5% benchmark by 6.8 points

Investment total return (including fair-value movements) fell 8.6% to $11.3m, profit before tax fell 12.3% to $9.3m, and net profit after tax fell 20.6% to $8.1m.

The balance sheet strengthened on absolute measures. Net assets attributable rose 11.5% to $224.7m, NTA per share rose 8.5% to $1.02, and dividend, interest and other investment income hit $0.9m, an unprecedented high against Annolyse's four-period historical baseline of $0.3m (range $0.2m–$0.5m). The interim dividend declared was 2.05 cents per share, up 10.2%, with 4.05 cents paid during the half.

For an investment company, the 6.8 point gap between Marlin's 3.7% portfolio return and the 10.5% benchmark is more material than the headline NPAT decline. The benchmark's 10.5% sits at the upper edge of Annolyse's historical baseline (mean 7.5%), so the relative shortfall reflects portfolio selection in a strong market rather than weak market conditions. A single half is not a trend, but it inverts the prior period's modest outperformance.

Distribution coverage from recurring income remains thin. Dividend and interest income of $0.9m covers only 15.9% of the $5.5m distributed to shareholders during the period. That is roughly double the prior-period coverage of 7.9%, but distributions remain overwhelmingly funded by realised and unrealised portfolio gains rather than yield. This matters because in any half where mark-to-market gains reverse, distributions draw on capital.

Earnings movement is largely a tax-rate effect. PBT fell 12.3% but NPAT fell 20.6%, an 8.3 percentage point gap explained by an effective tax rate of 12.7% versus 3.9% in the prior comparable. PBT is the cleaner operating read; both PBT and NPAT growth sit within Annolyse's historical range for this issuer.

For a listed investment company, the natural benchmark is the stated index comparator: on that test, the half underperformed, and the prior period's outperformance did not extend. NTA per share of $1.02 sits at the upper edge of the four-period historical range (mean $0.98), confirming that absolute wealth creation has continued even as relative performance weakened.

The release does not support a forward read on whether the benchmark gap is a stock-selection issue, a sector-tilt issue, or a currency timing issue, because no portfolio attribution detail was supplied in the excerpts available.

Of the $11.3m investment total return, only $0.9m is recurring dividend, interest and other income; the balance is profits on investments, which are mark-to-market driven and reverse in down markets. That composition is structural for an investment company, but it means the $8.1m NPAT is not a durable run-rate.

Two quality positives sit alongside the benchmark issue. Recurring investment income is at an unprecedented high versus the four-period baseline, lifting the floor under coverage. Cash and equivalents rose to $9.5m from $3.5m, and operating cash inflows of $8.4m reversed an $11.4m outflow in the prior comparable, reflecting investment activity timing rather than an operating quality signal.

ROE of 3.6% sits at the upper edge of Annolyse's historical range (mean 0.6%, range -7.1% to 5.1%) but is down from 5.1% in the prior comparable. The payout ratio against NPAT rose to 55.1% from 38.1%, which is sustainable only if portfolio gains continue at recent rates.

This briefing cannot assess portfolio attribution, individual holding performance, or management's expectations for benchmark-relative returns over the remainder of FY25.